Glenn Sblendorio

Glenn Sblendorio is a seasoned professional with extensive experience in finance, healthcare, and real estate investment. Currently serving as Managing Member of SBL IG of Florida, LLC, Glenn specializes in real estate investment across commercial, industrial, and residential properties in Florida. In the healthcare sector, Glenn has held various board positions, including Board Member and Chair roles at Amicus Therapeutics and Mineralys Therapeutics, and currently serves as Chairman of the Board at Nanoscope Therapeutics. Previously, Glenn was President and CEO of Iveric Bio, and held executive leadership roles in companies such as The Medicines Company, Eyetech Pharmaceuticals, Sony Interactive Entertainment, and Roche. Educational credentials include an Advanced Management Program from Harvard Business School and an MBA in Finance from Fairleigh Dickinson University.